Any stock, in context
BLISSGVS · Healthcare
Bliss GVS Pharma Limited
Observation · 15 Oct 2026
How these are readBliss GVS Pharma closed at ₹654.3 on 15 Oct 2026, 72.0% above its 200-day average and 4.9% above its 50-day average: above both lines. It sits 11.3% below its highest close of the past year, in the top fifth of its one-year range. Over three months it rose 35.3%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- Trade-for-trade (BE series)
- vs 200-day
- +72.0%
- the long line
- vs 50-day
- +4.9%
- the short line
- From 52w high
- −11.3%
- ₹118.0₹739.9
- 3 months
- +35.3%
- sector median −2.7% · 10 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · BE series (trade-for-trade) · median traded value ₹15 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.97%
- 1W
- –
- 1M
- −4.47%
- 3M
- +35.33%
- YTD
- –
- 1Y
- +334.04%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.